Converging neuropsychological and functional neuroimaging evidence indicates that the dorsal anterior cingulate cortex (dACC) is dysfunctional in drug-addicted populations. Few studies, however, have investigated the biochemical and physiological properties of the dACC in such populations. We used proton magnetic resonance spectroscopy ( 1 H-MRS) together with functional magnetic resonance imaging (fMRI) to probe dACC biochemistry and physiological activity during performance of a behavioural control task in 24 opiate-dependent individuals (maintained on a stable dose of methadone or buprenorphine at the time of study) and 24 age, gender, intelligence and performance-matched healthy subjects. While both groups activated the dACC to comparable levels, the opiate-using group displayed relatively increased task-related activation of frontal, parietal and cerebellar regions, as well as reduced concentrations of dACC N-acetylaspartate and glutamate/glutamine. In addition, the opiateusing group failed to show the expected correlations between dACC activation and behavioural measures of cognitive control. These findings suggest that the dACC is biochemically and physiologically abnormal in long-term opiate-dependent individuals. Furthermore, opiate addicts required increased, perhaps compensatory, involvement of the fronto-parietal and cerebellar behavioural regulation network to achieve normal levels of task performance/behavioural control. These neurobiological findings may partly underpin key addiction-related phenomena, such as poor inhibitory control of drug-related behaviour in the face of adverse consequences, and may be of relevance to the design of future treatment studies.
Introduction
Drug addiction involves a shift from intentional, controlled experimentation to uncontrolled, compulsive patterns of use. 1 While traditional neurobiological theories of addiction have focussed on positive and negative reinforcement, as well as sensitization of the brain's reward system, 2 more recent conceptualizations propose that disruption of cortical structures involved in the adaptive and inhibitory control of behaviour underlie addiction and addiction-related phenomena. [3] [4] [5] [6] [7] [8] Specifically, it has been posited that drug addiction involves disruption to a cingulo-fronto-parietal-cerebellar 'behavioural regulation' network that includes dorsal anterior cingulate cortex (dACC), supplementary motor area, dorsolateral prefrontal cortex, superior parietal area and cerebellum, [9] [10] [11] [12] [13] resulting in an impaired capacity to engage control over one's actions (i.e. drug use) in the face of adverse outcomes. 5, 12, 14, 15 However, very few studies have investigated the neural correlates of behavioural regulation in drug-using populations with the majority of these studies being conducted in cocaine-using populations. It is not clear whether chronic opiate use involves similar neurobiological disturbances.
Of the two existing functional magnetic resonance imaging (fMRI) studies in opiate dependent individuals, both have reported abnormally decreased activity of this cingulo-fronto-parietal-cerebellar neural network. 14, 16 These studies have implicated the dACC region in particular as being associated with performance deficits on tasks requiring behavioural control. Despite yielding consistent findings, both studies involved relatively small samples (n = between [11] [12] [13] and may have been confounded by performance differences between the addicted and healthy samples. That is, the performance deficits observed within their opiate-using samples complicates the interpretation of the reported brain-behaviour relationships (i.e., are such behavioural impairments a consequence of abnormal brain activation or vice versa?). 17 An alternative approach (e.g., performance matching the opiate using and comparison samples) would provide important insights into neurobiological underpinnings of previously observed behavioural control deficits.
To this end, by combining multiple sources of cognitive interference (e.g. Simon, Stroop, Flanker), the Multi-Source Interference Task (MSIT) has been specifically designed to facilitate examination of the functional integrity of the behavioural regulation neural network, particularly the dACC, at the singlesubject level. 11, 18 Importantly, it has also been shown that chronically ill psychiatric patients retain relatively intact performance on this task. 19 As such, the MSIT is likely to minimize confounds introduced by group differences in behavioural performance, as well as enabling robust individual level analyses of dACCrelated brain activity.
Interestingly, a recent study of healthy individuals by Grachev et al. 20 used proton magnetic resonance spectroscopy ( 1 H-MRS; an in vivo approach to measuring brain metabolite concentrations) to demonstrate a direct association between concentrations of a specific neuronal metabolite (N-acetylaspartate (NAA)) in the dACC and individual differences in measures of behavioural control (i.e., reaction timeinterference). NAA is a metabolite produced within neuronal mitochondria that reflects neuronal density and functional viability. 21, 22 Such biochemical-cognitive associations have not been explored in opiateusing populations. This finding and biochemical imaging technique (i.e. 1 H-MRS) offers the potential to more comprehensively investigate the neurobiological underpinnings of dACC-related behavioural and functional deficits reported in opiate-using populations. Indeed, signals other than NAA that are routinely detected by MRS may also provide important information regarding metabolic changes in opiate addiction. These signals include myoinositol, a metabolite for which an increase is associated with glial proliferation; choline-containing compounds, which are increased with changes in membrane turnover; creatine (including phosphocreatine), which participates in cell energy utilization; and glutamine/glutamate, amino acids involved in transmitter cycling and energy production. 23 Thus, concurrent analyses of these markers in the context of an fMRI experiment may provide clues regarding the biochemical basis of functional deficits identified in addicted populations.
In this study, we recruited twenty-four opiatedependent subjects and twenty-four age-, genderand intelligence-matched healthy controls. We used fMRI to scan subjects while they performed the MSIT, with the assumption that it would robustly activate the behavioural regulation network, particularly the dACC, and that there would be minimal performance differences between patients and controls. Concurrently, we acquired 1 H-MRS data from the dACC to obtain measures of specific brain metabolites that mark distinct aspects of neuronal integrity and function. In light of previous findings, 20 NAA was of particular interest. Combining 1 H-MRS and fMRI measurements allowed us to derive a detailed neurobiological characterization of dACC biochemistry and functional physiology in long-term opiatedependent subjects.
Materials and methods

Subjects
We recruited thirty opiate-dependent subjects from community drug and alcohol services and opiateprescribing general practitioners, as well as thirty healthy volunteers. Opiate-dependent subjects were required to have (i) a current IQ of > 70; (ii) be stable on their methadone/buprenorphine dose; (iii) be free of other psychotropic medications; and (iv) have no other current Axis I psychiatric diagnosis. All subjects with a history of significant head injury, neurological disease, electro-convulsive therapy, impaired thyroid function, and steroid use were excluded. Fifteen of the opiate-dependent subjects were still using other drugs on a weekly basis over the preceding 3 months (n = 4 heroin, n = 3 cannabis, n = 2 benzodiazepines, n = 2 heroin and cannabis, n = 3 cannabis and benzodiazepines, and n = 1 heroin and benzodiazepines). However, all subjects were required to abstain from using any substances for at least 24 h before the scanning session, although they were permitted to take their usual morning opiate prescription. All subjects gave written, informed consent to participate in this study, which was approved by local research and ethics committees.
Of the original cohort, six opiate users were excluded from the analyses because of structural abnormalities detected from their anatomical MR scans (n = 4 -prominent white matter hyperintensities; n = 1 -meningioma) or poor signal quality (n = 1). While it is possible that the white matter hyperintensities are a consequence of prolonged drug use, one cannot be certain that they are not due to other organic syndromes and as such, affected subjects were excluded to avoid the potential confounding of results. The remaining 24 opiate users were all stabilized on substitution therapy (n = 10 methadone; n = 14 buprenorphine). As seen in Table 1 , the opiate group was carefully matched for age, gender and intelligence to a healthy control sample with no significant differences between the two groups. At the time of scanning, the opiate users reported minimal levels of opiate withdrawal symptoms (as indexed by the Severity of Opiate Withdrawal Scale) 24 and moderate levels of psychological dependence (as indexed by the Severity of Dependence Scale). 25 Clinical and neuropsychological assessment All subjects were screened for the presence of an Axis I psychiatric diagnosis using the Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition. 26 A diagnosis of opiate dependence was established using the same structured interview. Opiates were the primary drug of abuse (current and lifetime) for the opiate-dependent sample. In this article, we use the terms dependence and addiction interchangeably. General intelligence (IQ) was assessed using the Wechsler Abbreviated Scale of Intelligence (WASI). 27 
Functional task
Full details of the MSIT appear elsewhere. 11, 18 Briefly, the MSIT is a response-conflict paradigm specifically designed to facilitate examination of the functional integrity of the behavioural regulation neural network, particularly the dACC, at the single-subject level. 11, 18 The MSIT achieves this by placing high demands on multiple dimensions of inhibitory control/performance monitoring circuits and utilizing a block-design to maximize statistical power to detect single-subject level activations. The task combines sources of interference from a number of well-known paradigms (i.e., Stroop, Flanker and Simon tasks) and generates a state of high response conflict by engaging competing response tendencies that code correct and incorrect outcomes. During scanning, participants viewed sets of three numbers from 0 to 3, presented in strings of three, with one number always being different to the other two. Subjects were instructed to indicate the identity (not the position) of the number that was different by pressing the appropriate button on a response box. Responses were made with one of three fingers; the index finger to indicate 1, the middle finger to indicate 2, and the ring (4th) finger to indicate 3. During congruent (C) task trials the number always matched the position on the response box and was flanked by the number 0. During incongruent (I) task trials, numbers never matched the response position and were flanked by incongruent numbers.
Subjects were informed that scans would begin and end with a fixation cross (fixation trials = F) for 60 seconds (s), between which they would see eight alternating blocks of C and I trials, lasting 30 s each (Figure 1 ). During the scanning trials, behaviour reaction times (RT) and percentage error scores were recorded via a notebook computer.
Imaging acquisition and pre-processing All individual MRI sequences were acquired in a single scanning session using a 3T GE Signa LX whole body scanner (GE Healthcare, Milwaukee, WI, USA). Before scanning, subjects were introduced to a 'mock scanner' in order to familiarize themselves with the MRI environment (for approximately 30 min). Following the mock session, subjects were taken to the actual scanner and had their head immobolized using a Velcro strap over the forehead. Scanning sequences consisted of a scout localizer, fMRI T1-weighted anatomical sequence and 1 H-MRS, in that order. Data were transferred to a Linux 2.4.27 workstation (Debian Sarge) for image pre-processing and analysis.
fMRI data were acquired as a series of single shot gradient-recalled echo-echo planar imaging (GRE-EPI) volumes providing T2*-weighted BOLD contrast. The image acquisition parameters for the functional scans were TR/TE/flip-angle, 3000 milliseconds (ms)/ 40 ms/601, FOV of 24 centimetres (cm) producing a voxel size of 1.875 Â 1.875 Â 4.0 millimetres (mm) and 25 slices for full-brain coverage. The first four images in each run were automatically discarded to allow the ) from the dACC bilaterally. MRS voxels were placed in each hemisphere, separated by the medial wall boundary of the frontal lobes, so as to encompass the dACC. The posterior boundary of the voxel was B10 mm posterior of a vertical line from the anterior commissure (AC) orthogonal to the AC-PC (posterior commissure) line. The inferior border was B5 mm superior to the top edge of the corpus callosum while the medial border was 1-2 slices lateral to the parasagittal slice on the T1 structural image for each hemisphere. For volume-localized spectra, absolute levels of N-acetyl compounds (NAA þ NAAG), creatine plus phosphocreatine (Cr), choline compounds (Cho), myoinositol (mI) and glutamate þ glutamine (Glx) were measured.
Statistical analyses
Individual demographic measures of sex, handedness, age and IQ were compared across groups using univariate analyses of variance (ANOVAs) in Statistical Package for the Social Sciences (SPSS) version 11.0. Analyses of behaviour data were conducted using repeated-measures ANOVAs with task condition (C and I blocks) as the within-subject effect and group (healthy subjects, opiate-dependent subjects) as the between-subject effect. Response errors were calculated by summing all commission (e.g., responding '1' when the correct answer was '2') and omission errors (missed responses) across the C and I trials. The response error variable was log 10 -transformed using standard procedures in SPSS to ensure normality of distribution. 28 Interference effects were calculated by subtracting the mean RT for the C trials across all blocks from the mean RT of the I trials across all blocks.
Analysis of the fMRI data was carried out using FEAT (fMRI Expert Analysis Tool) Version 5.4, part of FSL (FMRIB's Software Library, www.fmrib.ox.ac.uk/ fsl). The following pre-statistics processing was applied; motion correction using MCFLIRT; 29 nonbrain removal using BET; 30 spatial smoothing using a Gaussian kernel corresponding to a FWHM of 5 mm; mean-based intensity normalization of all volumes by the same factor; high-pass temporal filtering (Gaussian-weighted LSF straight line fitting, with sigma = 30.0 s). Time-series statistical analysis was carried out using FILM with local autocorrelation correction. 31 Individual subject Z (Gaussian transformed) statistical images were thresholded using clusters determined by Z > 2.7 and a whole-brain (corrected) cluster significance threshold of P = 0.05. 32 Of the 24 healthy subjects, 20 showed activation at this threshold, while 4 showed activation at a lowered Z-score of 2.33 (whole-brain cluster-wise corrected). All 24 patients with opiate dependence showed activation at the higher threshold of Z > 2.7 (wholebrain cluster-wise corrected). For each individual, we extracted a converted percentage signal change value of the BOLD response from the dACC cluster maxima using Featquery in FSL. To ensure that the cluster was indeed located in the dACC, we used the individuals' own high-resolution structural T1 image, as guided by our previously published operationalizations of dACC anatomy. 33, 34 We used the peak voxel signal for each individual in preference to summing activity over a larger area in a standard space (e.g., an area around the peak voxel or the MRS volume of interest) to minimize averaging over non-significant voxels. In previous work, we have found this individually tailored voxel is representative of the overall activated cluster and provides a more reliable association with the behavioural indices of MSIT performance (unpublished data).
Group-level analysis was carried out using FLAME (FMRIB's Local Analysis of Mixed Effects). 35, 36 For within-group analyses, Z (Gaussianized T/F) statistic images were determined using threshold of Z > 4.5, P < 0.05 whole-brain cluster-wise corrected. 32 To facilitate comparisons with existing literature, clusters are visually displayed (e.g., Figures 2 and 4) at a commonly reported threshold of Z > 3.0. For betweengroup comparisons, Z (Gaussianized T/F) statistic images were determined using a whole-brain (uncorrected) threshold of Z > 3.0, P < 0.0001. Registration to standard space images was carried out using FLIRT. 29, 37 Metabolite concentrations derived from proton MRS were determined for each ROI (corrected for estimated tissue content) with LCModel software. 38 This software utilized a library of reference spectra in a basis set recorded specifically for the scanner and calibrated using the tissue water signal as an internal standard. The LCModel fitting algorithm uses the multiple peaks contributing to an individual metabolite spectrum to estimate the tissue content of each metabolite. 38 Results are presented in institutional units approximating millimolar (ppm) concentration. The residual signal corresponds to, and is fitted by, additional broad peaks representing Examination of brain-behaviour-metabolite associations were conducted using Pearson product-moment correlations (simple linear regression) between the percentage signal change value of the blood-oxygenlevel-dependent (BOLD) response from the dACC cluster maxima, behaviour indices of RT-interference and response errors, and the brain metabolites derived from the proton MRS. ) comprising the lateral premotor, superior temporal and primary motor cortices. Opiate users showed relatively greater activation in seven clusters (z-score = 6.36-3.41, cluster size range = 149-21, all P-values < 1.0 Â 10 À3 ) with the largest difference being in the superior parietal regions. Other regions activated to a greater extent in opiate users included the inferior parietal, occipital and lateral prefrontal cortices, as well as the cerebellum (Table 2; Figure 2c ).
Results
Behaviour
Metabolite. Compared to healthy subjects, opiate users showed significant decreases in NAA and glutamate þ glutamine (Glx) concentrations (an 8% reduction for both; Table 3, Figure 3 ). No other group differences were observed for the other metabolites.
Behaviour-function-metabolite associations
There was no group difference in dACC %BOLD signal change (I-C) for each individual participant's maximal cluster of activity (healthy subjects: mean = 1.48%; opiate-dependent subjects: mean = 1.57%; main effect of group: F 1,46 = 0.16, P = 0.691). For healthy subjects, there was a significant positive correlation between dACC %BOLD signal change and both total response errors and RT-interference (r = 0.60, P = 0.002 and r = 0.49, P = 0.015, respectively; Figure 4 ). For opiate-dependent subjects, there was no significant correlation between dACC %BOLD signal change and response errors, while the association with RT-interference fell short of significance (r = À0.09, P = 0.34; r = 0.38, P = 0.07). A direct between groups comparison of the two correlation coefficients for response errors was significant (z = 2.54; Pp0.005). No other associations were found for either group between concentrations of NAA, Glx and either dACC %BOLD signal change or behaviour performance measures. Finally, no correlations were observed between clinical measures of opiate withdrawal or dependence and indices of MSIT task performance, %BOLD signal change or NAA or Glx concentrations (r-value range = 0.258-0.002; P-value range = 0.22-0.99).
Discussion
This is the first study to use multi-modal neuroimaging to investigate brain function and biochemistry in opiate-addicted individuals. The findings suggest that opiate addiction is associated with abnormalities in the neural substrates of behavioural regulation. Specifically, we found that opiate addicts (i) exhibited significantly reduced concentrations of NAA and glutamate/glutamine within the dACC, (ii) had relatively increased task-related activation of the fronto-parietal and cerebellar regions to achieve a comparable level of behavioural control as healthy subjects and (iii) failed to demonstrate the normal association between dACC physiological activity and behaviour measures (i.e., response errors) shown by the control group. Taken together, these findings suggest that neuronal abnormalities and a breakdown of normal brain-behaviour relationships within the dACC of opiate addicted individuals may result in the recruitment of a compensatory network of brain regions in situations requiring behavioural control. Previous investigations of the dACC in addiction have reported behavioural control related hypofunction in the presence of poorer task performance in opiate and cocaine users.
14,39 It should be noted that studies in abstinent cocaine users have found behavioural control related dACC hypofunction in the absence of any differences in task performance. 40 Our findings suggest that, when task performance is matched, opiate users are able to activate the dACC at comparable levels to healthy controls, but with additional recruitment of other brain regions thought to be involved in behavioural control. 41 Specifically, we found greater parietal, prefrontal and cerebellar activation in opiate users, which is consistent with previous findings. For example, Lee et al. 16 studied a group of opiate-dependent subjects and found a similar pattern of over-reliance on fronto-parietal regions during performance of a behavioural control task. Studies in other dependent populations, such as cocaine and alcohol users, have also observed similar patterns of hyperactivity in frontal, parietal and cerebellar regions. 12, 42 The pattern of results across these studies implies that chronic drug use leads to the recruitment of a compensatory network of brain regions in order to successfully detect and resolve conflicts in response tendencies. However, even though normative behavioural performance may be achieved in structured laboratory experiments, the same neural systems may be more vulnerable to fail in the real world, where emotional and motivational influences (e.g. stress, craving, withdrawal, etc.) also tax these cognitive and neural resources. 43, 44 Future investigations examining the effect of state behavioural and trait-related emotional and motivational influences of cognitive control in opiate-dependent subjects are likely to provide a more 'ecologically valid' picture of the dysfunction of these processes in real-world contexts.
Our proton MRS assessment of the dACC showed a marked reduction of NAA and Glx concentrations in opiate-dependent subjects. NAA is a metabolite produced within neuronal mitochondria, and is thought to reflect neuronal density and functional viability. 21, 45 The only study to date that used proton MRS in an opiate-dependent subjects found NAA decreases of similar magnitude in frontal grey matter. 46 It is interesting that unlike previous work in healthy individuals, the NAA metabolite reductions we identified were unrelated to behaviour measures of task performance and dACC physiological activity. [47] [48] [49] This would seem to suggest that, in opiate-addicted subjects, BOLD activity is not dependent on NAA levels, perhaps because the NAA reductions are dissociated from neuronal loss. NAA has several functions in the central nervous system, particularly the removal of metabolic water from neurons, neuronal-glial communication and the formation of myelin. 50 While there is some evidence to suggest that the rate of synthesis of NAA is associated with levels of energy metabolism and BOLD response in the human brain, [47] [48] [49] it is not clear how this relates to altered concentrations in addiction. One possibility relates to the growing evidence demonstrating that glia actually have higher metabolic rates than neurons. 51 As such, it is possible for NAA (which is synthesized exclusively in neurons) to reflect cortical pathology that is independent of the brains' physiological demand, particularly if the metabolic demand of the region is driven by glia rather than neurons (albeit, we did not find evidence of increased ml concentrations in patients). Alternatively the relationship previously reported by Grachev et al. may reflect specific characteristics of the sample and methodology employed (a much older sample, behavioural measures were generated using a less sensitive task design, and MRS data were ratios rather than absolute values).
It is as yet unclear whether these biochemical disturbances predate the onset of chronic drug use (i.e. represent potential markers of vulnerability) or reflect underlying neurobiological sequalae of the addicted brain. With respect to the latter, NAA abnormalities could reflect neurochemical adaptations related to tolerance phenomena, neurotoxicity associated with prolonged substance use or a combination of both. 52, 53 Additionally, the effect of druginduced hypoxia requires further investigation in light of evidence that NAA reductions in opiate-using populations may relate to acute decreases in systemic 54 and cortical 55 oxygenation following opiate injection (possibly related to associated respiratory depression). Such states of hypoxia are thought to occur regularly without clinical signs of overdosing. 54, 55 Accordingly, histological post-mortem studies in heroin users have shown evidence of ischaemic brain lesions, particularly those with an injecting history. 56 Thus, repeated transient opiateinduced hypoxia may have contributed to the NAA reduction observed in the current sample, given that all but one of the opiate-using subjects had a history of intravenous use. However, the fact that other addicted populations, such as cocaine and methamphetamine users, also show NAA reductions 52, 53, 57, 58 suggests that this neuronal deficit is not specific to opiate addiction. Future research examining the nature of these biochemical deficits should examine whether NAA reduction exists in non-pharmacological addictions, such as pathological gambling. Future studies should also consider the potential restorative effects of treatment and abstinence on brain metabolites and differences in brain activation in addicted patients, as the observed deficits may be partially or fully reversible. [59] [60] [61] Our finding of reduced Glx concentrations may be an indication of decreased dACC neuronal excitability in light of evidence that glutamate is the major excitatory neurotransmitter in the brain. [62] [63] [64] However, Glx is also involved in several metabolic processes and multiple pathways contribute to glutamine/glutamate metabolism. This suggests that the metabolic consequences and implications of changes in glutamine/glutamate are not readily attributed to Anterior cingulate dysfunction in opiate addiction M Yücel et al specific cell types. In neurons, the proportion of glucose metabolism contributing to neuronal glutamate turnover via a-ketoglutarate is of the order of 70% or more. 65, 66 This contrasts with glia, where < 20% of the glutamate content can be attributed to glucose metabolism. 66, 67 There is also a significant contribution to glutamine/glutamate distribution from the cycling of glutamate from neurons to glia, which convert glutamate into glutamine for transport back into the neurons (Magistretti cycle). 68 Finally, there is a contribution to the total tissue pool from anaplerotic metabolism. 69 However, despite multiple pools of glutamate and glutamine, and the difficulties in resolving the two metabolites in 1 H MRS spectra, it is likely that changes in the total Glx pool reflect some combination of altered flux through the tricarboxylic acid and the Magistretti cycles. Nevertheless, a reduction in Glx due to reduced flux through either of these pathways is likely to result in reduced neuronal excitability.
It is difficult to precisely identify how such alterations in Glx and neuronal excitability might be associated with addiction phenomena, largely because while the glutamatergic system has been implicated in addiction, [70] [71] [72] no previous studies have examined Glx metabolites in opiate-dependent subjects. Based upon a prominent model of addiction, 73 one may speculate that opiate addiction involves a breakdown in the role of glutamate in reinforcement learning, wherein subsets of neurons in the dACC participate in the formation of stimulus-reward associations and relay this associative information to sensorimotor structures by way of glutamatergic fibers. 73 This notion is supported by work in both humans 10, [74] [75] [76] and non-human primates [77] [78] [79] [80] that demonstrates selective increases in the firing rate of neuronal populations in the dACC when response selection is based on the expectancy and withdrawal of reward. Our findings provide an impetus for further research into the importance of Glx in understanding the neurobiological basis of reward-based learning and decision-making and how it relates to the phenomenology of addiction. Future research should also consider the importance of glutamatedopamine interactions and the proposed role of glutamate as a modulator of dopaminergic activity in addicted populations. 72 The lack of significant changes in other brain metabolites measured by MRS indicates that processes, such as altered lipid turnover (choline-containing metabolites), increased glial metabolism (myoinositol) and anaerobic metabolism (lactate), are unlikely to be primarily central to the pathophysiology of opiate addiction.
A potential limitation of the current study involves the implementation of the MSIT using a block-design fMRI paradigm. 11, 18 This approach is less suitable for characterizing discrete aspects of functional activation patterns associated with successful or failed response inhibition, commission of errors or dynamic performance adjustments. However, disentangling these subtle behavioural sub-processes was not the aim of the study nor the empirical justification of this task. 11, 18 Rather, we were interested in utilizing an fMRI paradigm that reliably probed the dACC and related behavioural regulation network at the individual level. The MSIT does exactly this by placing high demands on multiple dimensions of human cognitive control and utilizing a block-design to maximize statistical power (by improving signal-tonoise and summing activity across trials), so as to detect reliable single-subject level activations. This allows researchers to correlate functional activation patterns with individual differences in brain metabolites and behavioural control indices in order to better understand the nature of the relationships between these measures. Another potential limitation is that whereas we considered it important to match for behavioural performance (in order to interpret functional activation differences), it is possible that we sampled a biased or 'high-functioning' group of opiate addicts. This would serve to reduce any drug-related behavioural impairments if indeed poorer behavioural performance is related to drug use. However, the fact that we still found functional and biochemical differences would suggest that even in such samples, neurobiological deficits still exist. A further limitation relates to the recruitment of opiate addicted subjects maintained on opiate substitution therapy. This raises concerns as to whether the effects observed relate to differences in prescribed opiates across groups. However, given that similar findings have been reported in other addicted populations, 52 ,53,57,58 the abnormalities were not associated with clinical measures of opiate withdrawal, and there was no evidence of motor slowing (i.e. reaction time), substitution therapy is unlikely to explain the current findings. Furthermore, whilst a non-pharmacologically treated addicted group would be ideal, both short-and long-term withdrawal remains an issue within this population, and a stably medicated sample presents the best compromise, particularly in terms of generalizibility to the general population of opiate users. Finally, our focus was the examination of the dACC, and we did not therefore acquire MRS data from brain regions outside of this region of interest, limiting discussion about the specificity, but not novelty, of our findings.
Our findings of dACC metabolite changes and altered BOLD response to MSIT tasks extend current neurobiological models of addiction, which have traditionally focussed on reinforcement contingencies and sensitization of the brain's reward system, 2 by demonstrating a role for disturbances in cortical regions involved in behavioural control. Specifically, our findings suggest that opiate addicts have compromised dACC neuronal function and integrity, and require the additional involvement of other taskrelated brain regions to compensate and meet task demands. These findings hold promise for elucidating the neural underpinnings of addictive behaviour, such as poor control over drug use in the face of serious adverse consequences.
